Skip to main content
Log in

5-Hydroxytryptamine involvement in the locomotor activity suppressant effects of amphetamine in the mouse

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

d-Amphetamine, in doses lower than required to increase motor activity, reduced mouse spontaneous locomotor activity when this was assessed using cages equipped with photocell units, using treadwheels, or the measurement of spontaneous climbing behaviour. Actue treatments with the serotonergic agonists quipazine and 5-hydroxy-dl-tryptophan also reduced wheel running activity, spontaneous locomotor activity assessed using photocell cages, and spontaneous climbing behaviour; fenfluramine caused a similar effect. Pretreatment with 5-hydroxy-dl-tryptophan enhanced the inhibitory effects of d-amphetamine. A 3-day treatment with fenfluramine, or lesions of the median raphe nucleus (but not the dorsal raphe nucleus) abolished the ability of d-amphetamine to reduce motor activity in the three test systems. It is concluded that low doses of d-amphetamine can reduce locomotor activity and that the effects may be mediated via an enhancement of the release of 5-hydroxytryptamine from the system arising in the median raphe nucleus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Asin KE, Fibiger HC (1984) Spontaneous and delayed spatial alternation following damage to specific neuronal elements within the nucleus medians raphe. Behav Brain Res 13:241–250

    Google Scholar 

  • Balfour DJK, Iyaniwura TT (1985) An investigation of amphetamine-induced release of 5-HT from rat hippocampal slices. Eur J Pharmacol 109:395–399

    Google Scholar 

  • Boissier JR, Simon P, Fichelle J, Hervouet E (1965) Action psychoanaleptique de quelques anorexigènes dérivés de la phenyléthylamine. Thérapie 20:297–304

    Google Scholar 

  • Bradbury AJ, Costall B, Domeney AM, Jenner P, Kelly ME, Marsden CD, Naylor RJ, Smith JA (1985) Biochemical correlates of motor changes caused by the manipulation of dopamine function in the substantia nigra of the mouse. Neuropharmacology 24:1155–1161

    Google Scholar 

  • Costa E, Groppetti A, Revuelta A (1971) Action of fenfluramine on monamine stores of rat tissues. Br J Pharmacol 41:57–64

    Google Scholar 

  • Costall B, Naylor RJ (1975) The role of the raphe and extrapyramidal nuclei in the stereotyped and circling responses to quipazine. J Pharm Pharmacol 27:368–371

    Google Scholar 

  • Costall B, Eniojukan JF, Naylor JR (1982) Spontaneous climbing behaviour of mice, its measurement and dopaminergic involvement. Eur J Pharmacol 85:125–132

    Google Scholar 

  • Duhalt J, Verdavainne C (1967) Modification du taux de serotonine cerebrale chez la rat par les trifluoromethyl-phenyl-2-ethylaminopropane (fenfluramine, 768s). Arch Int Pharmacodyn Ther 170:276–286

    Google Scholar 

  • Fuller RW, Snoddy HD, Perry KW, Roush BB, Molloy FR (1976) The effect of quipazine on serotonin metabolism in rat brain. Life Sci 18:925–934

    Google Scholar 

  • Fuxe K (1965) Evidence for the existence of monoamine neurons in the central nervous system. IV. Distribution of monoamine nerve terminals in the central nervous system. Acta Physiol Scand [Suppl] 247:39–85

    Google Scholar 

  • Green RA, Gillin JC, Wyatt RJ (1976) The inhibitory effect of intraventricular administration of serotonin on spontaneous motor activity of rats. Psychopharmacology 51:81–84

    Google Scholar 

  • Harvey JA, McMaster SE, Fuller RW (1977) Comparison between the neurotoxic and serotonin-depletion effects of various halogenated derivatives of amphetamine in the rat. J Pharmacol Exp Ther 202:581–589

    Google Scholar 

  • Hunsinger RN, Wilson MC (1985) Alteration of the neurochemical effects of fenfluramine by previous treatment with d-amphetamine. Pharmacol Biochem Behav 22:127–134

    Google Scholar 

  • Hussey JS, Vincent ND, Davies JA (1983) The effect of low doses of d-amphetamine on drug-induced hyperactivity in the mouse. Psychopharmacology 81:327–331

    Google Scholar 

  • Jacobs B, Wise WD, Taylor KM (1974) Differential behavioural and neurochemical effects following lesions of the dorsal or median raphe nuclei in rats. Brain Res 79:35–361

    Google Scholar 

  • Jacobs BL, Trimbach C, Eubanks EE, Trulson M (1975a) Hippocampal mediation of raphe lesion- and PCPA-induced hyperactivity in the rat. Brain Res 94:253–261

    Google Scholar 

  • Jacobs BL, Wise WD, Taylor KM (1975b) Is their a catecholamine-serotonin interaction in the control of locomotor activity. Neuropharmacology 14:501–506

    Google Scholar 

  • Kelley AE, Winnock M, Stinus L (1986) Amphetamine, apomorphine and investigatory behaviour in the rat: analysis of the structure and pattern of responses. Psychopharmacology 88:66–74

    Google Scholar 

  • Kuczenski R (1979) Effects of para-chlorophenylalanine on amphetamine and haloperidol-induced changes in striatal dopamine turnover. Brain Res 164:217–225

    Google Scholar 

  • Lorens SA, Köhler C, Guldberg HC (1975) Lesions in Gudden's tegmental nuclei produce behavioural and 5-HT effects similar to those after raphe lesions. Pharmacol Biochem Behav 3:653–659

    Google Scholar 

  • Lorens SA, Guldberg HC, Hole K, Köhler C, Srebro B (1976) Activity, avoidance learning and regional 5-hydroxytryptamine following intra-brain stem 5,7-dihydroxytryptamine and electrolytic midbrain raphe lesions in the rat. Brain Res 108: 97–113

    Google Scholar 

  • Lucki I, Harvey JA (1979) Increased sensitivity to d- and l-amphetamine action after midbrain raphe lesions as measured by locomotor activity. Neuropharmacology 18:243–249

    Google Scholar 

  • Ponzio F, Consolazione A, Calderini G, Achilli G, Rochetti M, Algeri S (1981) Biochemical effects of quipazine on rat striatal dopaminergic system. Life Sci 29:83–91

    Google Scholar 

  • Randrup A, Munkvad I (1966) Role of catecholamines in the amphetamine excitation response. Nature (Lond) 211:540–542

    Google Scholar 

  • Robbins TW, Sahakian BJ (1983) Behavioural effects of psychomotor stimulant drugs: clinical and neuropsychological implications. In: Creese I (ed) Stimulants: Neurochemical, behavioural and chemical perspectives. Raven, New York, pp 301–338

    Google Scholar 

  • Slotnick BM, Leonard CA (1975) A stereotaxic atlas of albino mouse forebrain. US Government Printing Office, Washington

    Google Scholar 

  • Sloviter RS, Drust EG, Connor JD (1978) Evidence that serotonin mediates some behavioural effects of amphetamine. J Pharmacol Exp Ther 206:348–352

    Google Scholar 

  • Steranka LR, Sanders-Bush E (1979) Long term effects of fenfluramine on central serotonergic mechanisms. Neuropharmacology 18:895–903

    Google Scholar 

  • Trulson ME, Jacobs BL (1976) Behavioural evidence for the rapid release of CNS serotonin by PCA and fenfluramine. Eur J Pharmacol 36:149–154

    Google Scholar 

  • Warbritton JD, Stewart RM, Baldessarini RJ (1978) Decreased locomotor activity and attenuation of amphetamine hyperactivity with intraventricular infusion of serotonin in the rat. Brain Res 143:373–382

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bradbury, A.J., Costall, B., Naylor, R.J. et al. 5-Hydroxytryptamine involvement in the locomotor activity suppressant effects of amphetamine in the mouse. Psychopharmacology 93, 457–465 (1987). https://doi.org/10.1007/BF00207235

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00207235

Key words

Navigation